Related Experiment Video
Updated: Jan 6, 2026
08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
1.1K
AlphaFold for Docking Screens.
Amauri Duarte da Silva1, Walter Filgueira de Azevedo2
1Graduate Program in Information Technologies and Health Management, Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil.
Methods in Molecular Biology (Clifton, N.J.)
|October 11, 2025
Summary
This study uses AlphaFold protein structures and Molegro Virtual Docker to predict cyclin-dependent kinase 19 (CDK19) inhibition. A neural network model was built to guide anticancer drug development for CDK19, a protein lacking experimental data.
Area of Science:
- Computational biology
- Artificial intelligence in drug discovery
- Structural bioinformatics
Background:
- AlphaFold provides AI-generated protein 3D structures, accessible via the AlphaFold Protein Structure Database (AlphaFoldDB).
- Experimental structural data for certain proteins, like cyclin-dependent kinase 19 (CDK19), is often unavailable.
- CDK19 is a significant target for developing novel anticancer therapeutics.
Purpose of the Study:
- To demonstrate the utility of AlphaFold models in virtual screening and drug discovery workflows.
- To develop a predictive regression model for CDK19 inhibition using computational methods.
- To integrate AI-driven structural predictions with molecular docking simulations for drug target analysis.
Main Methods:
- Utilized AlphaFold-generated protein structures for docking screens with Molegro Virtual Docker.
- Employed Jupyter Notebooks to integrate docking simulations and analyze protein-ligand complex atomic coordinates.
- Constructed a neural network regression model using Molegro Data Modeller based on docking results and binding affinity data for CDK19 inhibitors.
Main Results:
- Successfully built a neural network regression model to predict CDK19 inhibition.
- Demonstrated a workflow integrating AlphaFold structures, docking, and machine learning for drug target modeling.
- Provided open-access datasets and Jupyter Notebooks for reproducibility and further research.
Conclusions:
- AlphaFold models can be effectively used in docking screens for drug discovery targeting proteins lacking experimental structural data.
- The developed computational approach facilitates the prediction of inhibitor efficacy for targets like CDK19.
- This study highlights the potential of AI and computational tools in accelerating anticancer drug development.
